| 常用名 | 罗美昔布 | CAS号 | 220991-20-8 |
|---|---|---|---|
| 价格 | $需询单/100g $需询单/1kg $需询单/100kg $需询单/1000kg | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 询单 |
| 产品详情(用途,包装等)
用途: Lumiracoxib, also known as CGS 35189 and COX 189, is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige. Since its original approval, lumiracoxib has been withdrawn from the market in several countries, mostly due to its potential for causing liver failure (sometimes requiring liver transplantation). It has never been approved for use in the United States. 物理化学性质: CAS号:220991-20-8 常用中文名:罗美昔布 常用英文名:Lumiracoxib 分子式:C15H13ClFNO2 分子量:293.721 密度:1.4±0.1 g/cm3 沸点:395.7±42.0 °C at 760 mmHg 熔点:139-141ºC 闪点:193.1±27.9 °C 储存条件:-20°C Freezer |